… are available for the treatment of COVID-19. Since there is no … treatments currently administered
in patients with COVID-19, … properties, their pharmacological features and achievement …

… the new coronavirus or coronavirus disease 2019 (COVID-19)… as Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-… The ongoing COVID-19 pandemic with significant mortality, …

… have published a detailed review of pharmacologic treatment options for Covid-19 in JAMA
(1). Two … As we look for pharmacologic treatments for COVID-19 patients, we should cast our …

… agents to both prevent and treat COVID-19. Although vaccines and specific drug … COVID-19.
In the present review, the drug candidates that have been suggested to treat COVID-19 will …

… health strategy to reduce the burden of COVID-19, the management of this disease …
pharmacological agents that have been developed and/or repurposed for the treatment of COVID-19. …

… treatment options, already existing pharmacological agents are repurposed for the potential
treatment of COVID-19 … repurposed pharmacological agents for the treatment of COVID-19 at …

… The aim of this review is to explore COVID-19 treatment options and … Pharmacological
treatments under evaluation … clinical trials (RCTs) for the treatment of COVID-19 are lacking. In the …

… to treat symptoms, including non-pharmacological treatments, as there is still no specific
treatment for COVID-19. … about non-pharmacological treatments used for COVID-19, addressing …

… treatments. Based on these premises, this review aims to discuss the most updated
pharmacological treatments to … to any current and future developments in curing COVID-19 …

… Taking into account the facts mentioned earlier, we conducted this review by focusing on
the pharmacologic treatment of patients with early COVID-19 (mild to moderate stages) from …